Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Tetsuya, Kashiwagi"'
Autor:
Takuya Nishino, Yoshiaki Kubota, Tetsuya Kashiwagi, Akio Hirama, Kuniya Asai, Masahiro Yasutake, Shinichiro Kumita
Publikováno v:
Renal Failure, Vol 46, Iss 1 (2024)
Acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT), secondary to cardiovascular disease and sepsis, is associated with high in-hospital mortality. Although studies have examined cardiovascular disease and sepsis in AKI, t
Externí odkaz:
https://doaj.org/article/8687f66446a1406ab9bd270ba7adf324
Autor:
Kohsuke Terada, Yorito Yanagida, Tomohiro Yan, Toshiki Funakoshi, Akio Hirama, Tetsuya Kashiwagi, Yukinao Sakai
Publikováno v:
Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-7 (2021)
Abstract Background The Japanese population is aging quickly. New methods of supporting peritoneal dialysis (PD) for elderly patients are essential if we are to increase the number of such patients. Methods We established a two-way communication syst
Externí odkaz:
https://doaj.org/article/58f1504282a5427b9db006f820103ec4
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Endocapillary proliferation occurs in various types of glomerulonephritis (GN), with varying prognoses. We examined 42 renal biopsy samples representing endocapillary proliferative lesions from post-streptococcal acute GN (PSAGN), Henoch–S
Externí odkaz:
https://doaj.org/article/c5311baf07594898b006d3ffba144134
Publikováno v:
Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Background Renal anemia is the important complication in patients undergoing peritoneal dialysis (PD), and heart failure (HF) is the important complication in patients on dialysis. Decreasing endogenous erythropoietin (EPO) in patients with
Externí odkaz:
https://doaj.org/article/3e936161c5564b3aa13acaea56c0d853
Publikováno v:
Journal of Nippon Medical School. 2022, Vol. 89 Issue 4, p360-367. 8p.
Autor:
Tomohiro Yan, Yukinao Sakai, Kohsuke Terada, Sho Okano, Sayuri Kawasaki, Tetsuya Kashiwagi, Masato Iwabu
Publikováno v:
International Medical Case Reports Journal. 15:557-561
Publikováno v:
Journal of Nippon Medical School. 89:360-367
Background Febuxostat is recommended for patients with chronic kidney disease (CKD) associated with hyperuricemia to lower the serum uric acid (sUA) concentration. However, it remains uncertain how this drug affects correlations between several labor
Autor:
Akio Hirama, Naoko Shimoda, Sayuri Kawasaki, Yukinao Sakai, Tetsuya Kashiwagi, Tomohiro Yan, Mariko Ikeda
Publikováno v:
Journal of Nippon Medical School. 89:287-294
Background Tolvaptan is the first effective drug treatment for autosomal dominant polycystic kidney disease (ADPKD) patients, but few long-term observations of the effects of tolvaptan have been reported. Methods In this single center, retrospective
Autor:
Momoko Arai, Akiko Mii, Akio Hirama, Tomohiro Kaneko, Tetsuya Kashiwagi, Akira Shimizu, Yukinao Sakai
Publikováno v:
CEN Case Rep
Immunoglobulin G (IgG) nephropathy refers to a rare group of diseases characterized by deposits of IgG in the mesangial region. However, IgG nephropathy is controversial as a single disease entity, and its pathogenesis remains to be elucidated. In th
Publikováno v:
Kidney International Reports. 7:1229-1240
Focal segmental glomerular sclerosis (FSGS) is caused by podocyte injury. It is characterized by obliteration of glomerular capillary tufts with increased extracellular matrix (ECM). Altered communication between podocytes and glomerular endothelial